BACKGROUND AND PURPOSE: Many processes involved in the pathogenesis of atherosclerosis result in modifications of the extracellular matrix. These changes not only determine the mechanical stability of atherosclerotic lesions but can directly or indirectly influence further development of the lesions. The purpose of the present study was to compare the matrix composition of human carotid plaques from symptomatic patients with those obtained from patients without symptoms. Furthermore, matrix changes related to age were studied. METHODS: Thirty atherosclerotic carotid plaques were removed by endarterectomy from 27 patients and divided into 2 groups on the basis of the presence of ipsilateral symptoms. The plaques were homogenized, and the total levels of the major components of the extracellular matrix were determined. RESULTS: Plaques associated with symptoms were characterized by increased levels of elastin (1.58+/-0.46 versus 1.24+/-0.40 mg/g wet wt; P=0.03) and decreased levels of hydroxyapatite (45.1+/-46.3 versus 131.4+/-111.7 mg/g wet wt; P=0.02) compared with asymptomatic plaques. The increase in elastin in plaques from symptomatic patients was due to elevated levels of an intermediate-size fraction, as determined by liquid chromatography. Collagen and sulfated glycosaminoglycans were present in equal amounts in both groups. Elastin content in carotid plaques decreased with age. CONCLUSIONS: Carotid plaques from symptomatic patients have lower levels of hydroxyapatite than those from asymptomatic patients. The present study also raises the possibility that non-cross-linked forms of elastin, increased in plaques associated with symptoms, could be a marker of plaque vulnerability and/or directly induce harmful cellular activities or increase lipoprotein retention in the vascular wall.
BACKGROUND AND PURPOSE: Many processes involved in the pathogenesis of atherosclerosis result in modifications of the extracellular matrix. These changes not only determine the mechanical stability of atherosclerotic lesions but can directly or indirectly influence further development of the lesions. The purpose of the present study was to compare the matrix composition of human carotid plaques from symptomatic patients with those obtained from patients without symptoms. Furthermore, matrix changes related to age were studied. METHODS: Thirty atherosclerotic carotid plaques were removed by endarterectomy from 27 patients and divided into 2 groups on the basis of the presence of ipsilateral symptoms. The plaques were homogenized, and the total levels of the major components of the extracellular matrix were determined. RESULTS: Plaques associated with symptoms were characterized by increased levels of elastin (1.58+/-0.46 versus 1.24+/-0.40 mg/g wet wt; P=0.03) and decreased levels of hydroxyapatite (45.1+/-46.3 versus 131.4+/-111.7 mg/g wet wt; P=0.02) compared with asymptomatic plaques. The increase in elastin in plaques from symptomatic patients was due to elevated levels of an intermediate-size fraction, as determined by liquid chromatography. Collagen and sulfated glycosaminoglycans were present in equal amounts in both groups. Elastin content in carotid plaques decreased with age. CONCLUSIONS: Carotid plaques from symptomatic patients have lower levels of hydroxyapatite than those from asymptomatic patients. The present study also raises the possibility that non-cross-linked forms of elastin, increased in plaques associated with symptoms, could be a marker of plaque vulnerability and/or directly induce harmful cellular activities or increase lipoprotein retention in the vascular wall.
Authors: Lisa M Berglund; Olga Kotova; Peter Osmark; Helena Grufman; Chen Xing; Marie-Louise Lydrup; Isabel Goncalves; Michael V Autieri; Maria F Gomez Journal: Cardiovasc Res Date: 2011-11-23 Impact factor: 10.787
Authors: Russell H Behler; Timothy C Nichols; Hongtu Zhu; Elizabeth P Merricks; Caterina M Gallippi Journal: Ultrasound Med Biol Date: 2008-11-21 Impact factor: 2.998
Authors: Mariette E C Waaijer; David A Gunn; Sharon D Catt; Michael van Ginkel; Anton J M de Craen; Nicole M Hudson; Diana van Heemst; P Eline Slagboom; Rudi G J Westendorp; Andrea B Maier Journal: Age (Dordr) Date: 2011-09-10
Authors: Giuseppe Asciutto; Nuno V Dias; Andreas Edsfeldt; Mihaela Nitulescu; Ana Persson; Marie Nilsson; Pontus Dunér; Jan Nilsson; Isabel Gonçalves Journal: PLoS One Date: 2015-03-24 Impact factor: 3.240
Authors: Isabel Gonçalves; Andreas Edsfeldt; Helen M Colhoun; Angela C Shore; Carlo Palombo; Andrea Natali; Gunilla Nordin Fredrikson; Harry Björkbacka; Maria Wigren; Eva Bengtsson; Gerd Östling; Kunihiko Aizawa; Francesco Casanova; Margaretha Persson; Kim Gooding; Phil Gates; Faisel Khan; Helen C Looker; Fiona Adams; Jill Belch; Silvia Pinnola; Elena Venturi; Michaela Kozakova; Li-Ming Gan; Volker Schnecke; Jan Nilsson Journal: BMC Cardiovasc Disord Date: 2016-09-05 Impact factor: 2.298
Authors: Eva Bengtsson; Karin Hultman; Pontus Dunér; Giuseppe Asciutto; Peter Almgren; Marju Orho-Melander; Olle Melander; Jan Nilsson; Anna Hultgårdh-Nilsson; Isabel Gonçalves Journal: Sci Rep Date: 2017-06-16 Impact factor: 4.379
Authors: Isabel Gonçalves; Mihaela Nitulescu; Takaomi C Saido; Nuno Dias; Luis M Pedro; José Fernandes E Fernandes; Mikko P S Ares; Isabella Pörn-Ares Journal: BMC Cardiovasc Disord Date: 2009-06-18 Impact factor: 2.298
Authors: Michael Lacy; Christina Bürger; Annelie Shami; Maiwand Ahmadsei; Holger Winkels; Katrin Nitz; Claudia M van Tiel; Tom T P Seijkens; Pascal J H Kusters; Ela Karshovka; Koen H M Prange; Yuting Wu; Sanne L N Brouns; Sigrid Unterlugauer; Marijke J E Kuijpers; Myrthe E Reiche; Sabine Steffens; Andreas Edsfeldt; Remco T A Megens; Johan W M Heemskerk; Isabel Goncalves; Christian Weber; Norbert Gerdes; Dorothee Atzler; Esther Lutgens Journal: Nat Commun Date: 2021-06-18 Impact factor: 14.919